Hinge Health lands big Series D, becomes first San Francisco unicorn of new year

San Francisco digital health startup Hinge Health, which offers solutions to treat chronic back and joint pain, has closed on a $310 million Series D round, bringing its valuation well into unicorn territory, TechCrunch reports. The funding round, led by Coatue and Tiger Global, has reportedly sent Hinge's valuation to $3 billion, a massive increase from the company's previous valuation of about $405 million as of April 2020, according to PitchBook. In February 2020, the company announced that…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news